CFGS
SBIO icon

Concourse Financial Group Securities’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Concourse Financial Group Securities’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,971
Closed -$99.3K – 2391
2018
Q4 		$83K Buy
2,971
+505
+20% +$16.7K 0.01% 674
2018
Q3 		$97K Buy
+2,466
New +$93.5K 0.03% 432

Other funds holding SBIO

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return

Concourse Financial Group Securities's SBIO Position: Q1 2019 in Review

Concourse Financial Group Securities sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2019, closing a stake of 2,971 shares — an estimated $99.3K sold.

Concourse Financial Group Securities first reported a position in SBIO in Q3 2018 and held it in 2 quarters. The position peaked at $97K in Q3 2018. 47 funds tracked by Wall St. Rank hold SBIO as of Q1 2019.

  • Concourse Financial Group Securities reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2019 after selling out during the quarter.
  • Concourse Financial Group Securities sold 2,971 ALPS Medical Breakthroughs ETF shares in Q1 2019, an estimated $99.3K.
  • Concourse Financial Group Securities first reported a position in ALPS Medical Breakthroughs ETF in Q3 2018 and held it in 2 quarters.
  • Concourse Financial Group Securities's ALPS Medical Breakthroughs ETF position peaked at $97K in Q3 2018.
  • 47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2019.

Based on Concourse Financial Group Securities's 13F filing for Q1 2019, filed 15 May 2019.